The Korea Ladies Professional Golf Tour (KLPGT) announced on the 11th that it held a signing ceremony for the 'KLPGA 2023 Pharmaresearch Rejuran Dream Tour Championship'.
Kim Shin-gyu, CEO of Pharma Research (left), and Kang Chun-ja, CEO of KLPGT, are posing for a commemorative photo at the signing ceremony of the KLPGA 2023 Pharma Research Rejuran Dream Tour Championship. [Photo by KLPGA]
This tournament, which determines the strongest player on the Dream Tour, will be held from October 23 to 25 in a 54-hole stroke play format. The total prize money is 200 million KRW. Kim Shin-gyu, CEO of Pharmaresearch, said, "Following the establishment of a golf team focused on promising young players this year, it is very meaningful and an honor to be able to host the Dream Tour Championship, the biggest gateway for these hopefuls to achieve their dreams." He added, "Pharmaresearch Rejuran will continue to fulfill its role as a co-growth brand that not only successfully hosts tournaments but also helps nurture the dreams of promising players."
Kang Chun-ja, CEO of KLPGT, responded, "We are very pleased to partner with Pharmaresearch and the Dream Tour," and added, "We expect this tournament to be a valuable opportunity for the players."
Pharmaresearch is a regenerative medicine specialized company that manufactures and sells pharmaceuticals, medical devices, cosmetics, and health functional foods. In addition to hosting the Dream Tour Championship, it is also committed to the development of women's golf through player sponsorships. The Pharmaresearch Rejuran golf team includes promising players such as Ma Seo-young (20), Yoon Soo-ah (21), Kang Chae-yeon (20), Kim Tae-hee (20), and Lee Joo-yeon (20).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
